These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20493965)

  • 21. Lead Integrity Alert Is Useful for Assessment of Performance of Biotronik Linox Leads.
    Steinberg C; Padfield GJ; Hahn E; Flavelle S; McILROY C; VAN Bremen O; Yeung-Lai-Wah JA; Kerr CR; Deyell MW; Tung SK; Andrade JG; Bennett MT; Bashir JG; Krahn AD; Chakrabarti S
    J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1340-5. PubMed ID: 26471861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medtronic Sprint Fidelis lead recall: determining the initial 5-year management cost to Medicare.
    Mehrotra AK; Knight BP; Smelley MP; Shah DP; Weisberg I; Baez-Escudero J; Beshai JF; Burke MC
    Heart Rhythm; 2011 Aug; 8(8):1192-7. PubMed ID: 21377552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history of the Sprint Fidelis lead: survival analysis from a large single-center study.
    Tzogias L; Bellavia D; Sharma S; Donohue TJ; Schoenfeld MH
    J Interv Card Electrophysiol; 2012 Jun; 34(1):37-44. PubMed ID: 22314669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of implanted recalled sprint Fidelis lead on patient mortality.
    Morrison TB; Friedman PA; Kallinen LM; Hodge DO; Crusan D; Kumar K; Hayes DL; Rea RF; Hauser RG
    J Am Coll Cardiol; 2011 Jul; 58(3):278-83. PubMed ID: 21737019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial injury secondary to ICD shocks: insights from patients with lead fracture.
    Sham'a RA; Nery P; Sadek M; Yung D; Redpath C; Perrin M; Sarak B; Birnie D
    Pacing Clin Electrophysiol; 2014 Feb; 37(2):237-41. PubMed ID: 23998856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis of high-voltage conductor fractures in Sprint Fidelis leads.
    Koneru JN; Gunderson BD; Sachanandani H; Wohl BN; Kendall KT; Swerdlow CD; Ellenbogen KA
    Heart Rhythm; 2013 Jun; 10(6):813-8. PubMed ID: 23454808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Sprint Fidelis implantable cardioverter-defibrillator (ICD) leads (Medtronic, Inc., Minneapolis, MN, USA) were removed from the market in October 2007 because of the rate of pace-sense conductor fractures.
    Arias MA; Puchol A; Castellanos E; Pachón M
    Heart Rhythm; 2009 Jan; 6(1):e6-7; author reply e7. PubMed ID: 19121790
    [No Abstract]   [Full Text] [Related]  

  • 28. The Impact of Inappropriate Implantable Cardiac Defibrillator Shocks on Cardiovascular Morbidity and Mortality.
    Mehta NK; Taylor M; Kalbfleisch S
    Pacing Clin Electrophysiol; 2016 Aug; 39(8):858-62. PubMed ID: 27197050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of longevity and clinical outcomes of implantable cardioverter-defibrillator leads among manufacturers.
    Kawada S; Nishii N; Morimoto Y; Miyoshi A; Tachibana M; Sugiyama H; Nakagawa K; Watanabe A; Morita H; Ito H
    Heart Rhythm; 2017 Oct; 14(10):1496-1503. PubMed ID: 28502870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on small-diameter implantable cardioverter-defibrillator leads performance.
    van Rees JB; van Welsenes GH; Borleffs CJ; Thijssen J; van der Velde ET; van der Wall EE; van Erven L; Schalij MJ
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):652-8. PubMed ID: 22352338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of pacing/defibrillator lead failure using device diagnostics and pacing maneuvers.
    Chung EH; Casavant D; John RM
    Pacing Clin Electrophysiol; 2009 Apr; 32(4):547-9. PubMed ID: 19335868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Sprint Fidelis and Riata defibrillator lead failure rates.
    Fazal IA; Shepherd EJ; Tynan M; Plummer CJ; McComb JM
    Int J Cardiol; 2013 Sep; 168(2):848-52. PubMed ID: 23138013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age.
    Girerd N; Nonin E; Pinot J; Morel E; Flys C; Scridon A; Chevalier P
    Arch Cardiovasc Dis; 2011; 104(6-7):388-95. PubMed ID: 21798471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead.
    Morrison TB; Rea RF; Hodge DO; Crusan D; Koestler C; Asirvatham SJ; Bradley D; Shen WK; Munger TM; Hammill SC; Friedman PA
    J Cardiovasc Electrophysiol; 2010 Jun; 21(6):671-7. PubMed ID: 20082653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detailed electrical analysis of lead failures in a small-scaled right ventricular defibrillator lead: reality of Sprint Fidelis medical device recalls.
    Kreuz J; Balta O; Zimmer S; Fimmers R; Lickfett L; Mellert F; Nickenig G; Schwab JO
    Hellenic J Cardiol; 2010; 51(3):219-25. PubMed ID: 20515854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biventricular implantable cardioverter defibrillator right ventricle pace-sense ring electrode failure: lead switch fix.
    Venkataraman G; Moore H; Karasik P; Singh S; Fletcher R
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):899-903. PubMed ID: 18684289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generator exchange is associated with an increased rate of Sprint Fidelis lead failure.
    Lovelock JD; Patel A; Mengistu A; Hoskins M; El-Chami M; Lloyd MS; Leon A; DeLurgio D; Langberg JJ
    Heart Rhythm; 2012 Oct; 9(10):1615-8. PubMed ID: 22683747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads.
    Ellis CR; Rottman JN
    Heart Rhythm; 2009 May; 6(5):619-24. PubMed ID: 19389648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sprint Fidelis implantable cardioverter-defibrillators lead patient management and survival: Single center study.
    Grabowski M; Rokicki JK; Gajda S; Januszkiewicz Ł; Cacko A; Stolarz P; Opolski G
    Cardiol J; 2017; 24(3):259-265. PubMed ID: 27910085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.